Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Communications Medicine|May 22, 2024
Structure-specific rigid dose accumulation dosimetric analysis of ablative stereotactic MRI-guided adaptive radiation therapy in ultracentral lung lesionsJ M Bryant, Ruben J Cruz-Chamorro, Alberic Gan, et al.
Oncotarget|September 3, 2016
Combining radiomic features with a miRNA classifier may improve prediction of malignant pathology for pancreatic intraductal papillary mucinous neoplasmsJennifer B Permuth, Jung Choi, Yoganand Balarunathan, et al.
Prostate Cancer and Prostatic Diseases|July 12, 2020
Proof-of-principle Phase I results of combining nivolumab with brachytherapy and external beam radiation therapy for Grade Group 5 prostate cancer: safety, feasibility, and exploratory analysisZhigang Yuan, Daniel Fernandez, Jasreman Dhillon, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2020
Prospective Single-Arm Phase 1 and 2 Study: Ipilimumab and Nivolumab With Thoracic Radiation Therapy After Platinum Chemotherapy in Extensive-Stage Small Cell Lung CancerBradford A Perez, Sungjune Kim, Minhsuan Wang, et al.
Biorxiv : the Preprint Server for Biology|October 28, 2024
Nanoparticles use magnetoelectricity to target and eradicate cancer cellsJohn Michael Bryant, Emmanuel Stimphil, Victoria Andre, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 3, 2025
Magnetoelectric Nanotherapy Achieves Complete Tumor Ablation and Prolonged Survival in Pancreatic Cancer Murine ModelsJohn Michael Bryant, Max Shotbolt, Emmanuel Stimphil, et al.
BMC Cancer|April 9, 2024
Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcomaArash O Naghavi, J M Bryant, Youngchul Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|January 19, 2023
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung CancerCasey L Liveringhouse, Kujtim Latifi, Amalin G Asous, et al.
Journal for Immunotherapy of Cancer|May 4, 2026
Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancerJohn Michael Bryant, Maria Sandoval, Ryan Putney, et al.
Pageof 8